Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Premier buys the rest of direct sourcer S2S Global
Group purchasing organization Premier has paid for the remaining 40% of S2S Global that it didn’t already own.
Read more
2. Insulet extends OmniPod integration deal with Abbott
Insulet extends its long-standing exclusive agreement with Abbott Laboratories for the integration of Abbott’s FreeStyle blood-glucose monitoring technology into its OmniPod tubeless insulin-pump system.
1. Medtronic’s new Ev3 unit pays $1.3m in whistleblower suit
The Ev3 subsidiary Medtronic (NYSE:MDT) acquired along with Covidien yesterday delivered good news and bad: FDA clearance for a new aneurysm treatment and a $1.25 million hit in a whistleblower lawsuit.
The U.S. Justice Dept. said Medtronic agreed to the settlement without admitting any wrongdoing. The qui tam lawsuit, filed by former sales rep Amanda Cashi, alleged that Ev3 acquisition FoxHollow Technologies urged hospitals to bill Medicare for inpatient procedures in atherectomies performed using its Silver Fox device.
